endocannabinoid system
The body's natural pain-killing and mood-regulating molecular system; a potential target for editing-based, non-opioid pain treatment.
As defined in 112 | Fyodor Urnov on Gene Editing, CRISPR, and Human Engineering
Other definitions
Signaling system in the body that cannabinoids such as CBD and THC interact with and that the cannabis industry seeks to stimulate.
Quality and Innovation
Where it comes up · 2
- 112 | Fyodor Urnov on Gene Editing, CRISPR, and Human Engineering2 claims
- Quality and Innovation1 claim
Most important claims · 3 of 3Search all claims for “endocannabinoid system” →
- Within the next five to ten years, gene editing will deliver dramatic advances—more cures for certain cancers via editing the immune system, substantial reduction of the burden of sickle cell disease and hemophilia, non-addictive treatment of chronic pain by editing pain or endocannabinoid genes, and prevention of heart attacks by deleting PCSK9—though prediction beyond ten years is impossible because future technologies are unknowable.112 | Fyodor Urnov on Gene Editing, CRISPR, and Human Engineering
- Because certain people naturally lack genes required to transmit pain (and others naturally have an over-active endocannabinoid system), gene editing those systems could create a non-opioid, non-addictive treatment for chronic and breakthrough cancer pain—potentially entering the clinic in three to five years.112 | Fyodor Urnov on Gene Editing, CRISPR, and Human Engineering
- The cannabinoid industry has discussed quality the way food did, focusing on CBD and THC and then complex minor cannabinoids, while neglecting growing and processing, including the solvents used in extraction, which most company staff cannot explain.Quality and Innovation